ArticleOncoTargets and therapy2016

New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer.

Ji-Chun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.